Impossible Foods and Motif Foodworks have settled their patent infringement dispute over heme protein. As part of the settlement, Impossible Foods will take over Motif FoodWorks' heme business, which produces Hemami, a protein identical to bovine myoglobin.

The case was dismissed with prejudice, meaning the same legal claim cannot be filed again, and each company will bear its costs and expenses. According to the companies, this affirms Impossible Foods' category leadership in heme-related products, while Motif FoodWorks and Ginkgo Bioworks will continue supporting growth and innovation in the plant-based sector.

Analyst QuickTake: This development marks a significant milestone for Impossible Foods, which has been entangled in this legal battle since early 2022 . Additionally, the timing aligns with the company’s recent provisional approval from the EFSA for the use of heme. This step could pave the way for launching heme-containing products in the EU countries, pending further review.